Metraipolis › archive › dc_cd651e08cd75

Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments — Europe PMC PMID:41150795

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41150795
DOI: 10.3390/cimb47100846
License (as archived): solo-consultazione
Archived: 2026-11-09T07:31:49.182Z
SHA-256 of the archived text: e55b59f33f8378d16360a751dc8ed7a73b28c6e4dd42676df6be87963eaea74c
Stable URL of this page: https://metraipolis.com/documento/dc_cd651e08cd75

How to cite

Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments — Europe PMC PMID:41150795 — Europe PMC (en), https://europepmc.org/article/MED/41150795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd651e08cd75 (Metraipolis archive dc_cd651e08cd75, sha256 e55b59f33f8378d16360a751dc8ed7a73b28c6e4dd42676df6be87963eaea74c)

BibTeX

@misc{dccd651e08cd75,
  title = {Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments — Europe PMC PMID:41150795},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41150795},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd651e08cd75; sha256 e55b59f33f8378d16360a751dc8ed7a73b28c6e4dd42676df6be87963eaea74c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41150795. Agents can read the archived copy with the MCP tool read_document.